InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,312.80
(
0.08%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
73.75
(
0.01%
)
Bitcoin
62,925.16
(
-0.64%
)
Post# of 253199
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 125
Posts 21117
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: None

Tuesday, 09/19/2017 11:45:39 AM

Tuesday, September 19, 2017 11:45:39 AM

Post# of 253199
MYOK new high on data update

https://globenewswire.com/news-release/2017/09/18/1124266/0/en/MyoKardia-Presents-Additional-Positive-Data-from-Phase-2-PIONEER-HCM-Study-of-Mavacamten-Formerly-MYK-461-at-the-Heart-Failure-Society-of-America-s-21st-Annual

My guess is that they will apply for Break through therapy designation in the 4th Qt 2017 .
Currently Fast Tracked

Does anyone see any problems with their story ?

Kiwi
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up